Literature DB >> 402767

Effect of blood transfusion on the immune response of children with thalassaemia.

F Kanakoudi-Tsakalidis, K Spyroglou, R Tzafi, C Cassimos.   

Abstract

The effect of blood transfusions on the immune response of 46 thalassaemic children was studied. Cell-mediated immune response was evaluated by performing skin tests to specific (streptokinase-streptodornase and candidin) and nonspecific (dinitrochlorobenzene and phytohaemagglutinin) antigens. Antibody response to specific antigen (tetanus toxoid) was estimated by measuring the tetanus antitoxin titre before and after vaccination. No gross impairment of cell-mediated immunity was elicited. The larger proportion of negative phytohaemagglutinin skin tests found in thalassaemic patients does not necessarily suggest a cell-mediated immunity impairment, since this skin reaction is also affected by other factors, especially the inflammatory skin response. The transfused antibodies may inhibit the recipient's sensitization and primary immune response to the homologous antigen, especially when the antibody level in the transfused blood is high whereas the secondary immune response is not affected.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402767     DOI: 10.1159/000207861

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Serum immunoglobulins, IgG subclasses, isohemagglutinins and complement-3 levels in patients with thalassemia major.

Authors:  C Vergin; N Kutukculer; N Cetingul; G Nisli; S Caglayan; S Oztop
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Lymphocyte changes in beta-thalassaemia major.

Authors:  S Musumeci; G Schiliro; M A Romeo; A Sciotto; A Rosalba; G Pizzarelli
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

3.  Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major.

Authors:  G Pardalos; F Kanakoudi-Tsakalidis; M Malaka-Zafiriu; H Tsantali; M Athanasiou-Metaxa; G Kallinikos; G Papaevangelou
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.